In addition, vactosertib inhibited TGF-β-stimulated TIMP-1 secretion by HSCs, as well as the TIMP-1-induced proliferation, motility, and survival of HCC cell lines (SK-HEP1, SNU354, and HepG2). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.